Frequency of blood glucose monitoring in relation to glycaemic control: Observational study with diabetes database

British Medical Journal

Volumn 318, Issue 7202, 1999, Pages 83-86

  Evans, Josie M M ^a   Newton, Ray W ^a   Ruta, Danny A ^a   MacDonald, Thomas M ^a   Stevenson, Richard J ^a   Morris, Andrew D ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A; INSULIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD GLUCOSE MONITORING; CHILD; DATA BASE; DIABETES CONTROL; FEMALE; GLUCOSE BLOOD LEVEL; HOME MONITORING; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; TEST STRIP; UNITED KINGDOM; AGE; ANALYTICAL EQUIPMENT; BLOOD; DIABETES MELLITUS; FACTUAL DATABASE; METABOLISM; PATIENT COMPLIANCE; SOCIOECONOMICS;

AGE FACTORS; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; DATABASES, FACTUAL; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; HUMANS; INSULIN; PATIENT COMPLIANCE; REAGENT KITS, DIAGNOSTIC; SOCIOECONOMIC FACTORS;

EID: 0033542663     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.319.7202.83     Document Type: Article

References (24)

1. DCCT Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New Engl J Med 1989;329:977-86.
2. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and the risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837-53.
3. Consensus statement on self-monitoring of blood glucose. Diabetes Care 1987;10:95-7.
4. American Diabetes Association. Consensus statement on self-monitoring of blood glucose. Diabetes Care 1994;17:81-6.
5. Harris MI, Cowie CC, Howie LJ. Self-monitoring of blood glucose by adults with diabetes in die United States population. Diabetes Care 1993;10:1116-23.
6. Gallichan M. Self monitoring of blood glucose by people with diabetes: evidence based practice. BMJ 1997;31:964-6.
7. Daneman D, Siminerio L, Transue D, Betschart J, Drash A, Becker D. The role of self-monitoring of blood glucose in the routine management of children with insulin-dependent diabetes mellitus. Diabetes Care 1985;8:1-4.
8. Belmonte MM, Schiffrin A, Dufresne J, Suissa S, Goldman H, Polychronakos C. Impact of SMBG on control of diabetes as measured by HbA1. Diabetes Care 1988;11:484-8.
9. Newman WP, Laqua D, Engelbrecht D. Impact of glucose self-monitoring on glycohemoglobin values in a veteran population. Arch Intern Med 1990;150:107-10.
10. Worth R, Home PD, Johnston DG, Anderson J, Ashworth L, Burrin JM, et al. Intensive attention improves glycaemic control in insulin-dependent diabetes without further advantage from home blood glucose monitoring. BMJ 1982;285:1233-40.
11. Gordon D, Semple CG, Paterson KR. Do different frequencies of self-monitoring of blood glucose influence control in type 1 diabetic patients. Diabetic Med 1991;8:679-82.
12. Gill GA, Huddle KR. Assessment of glycaemic control in the diabetic clinic. Pract Diabetes 1989;6:77-9.
13. Patrick AW, Gill GV, MacFarlane IA, Cullen A, Power E, Wallymahmed M. Home glucose monitoring in type 2 diabetes: is it a waste of time? Diabetic Med 1994;11:62-5.
14. Evans JMM, McDevitt DG, MacDonald TM. The Tayside medicines monitoring unit (MEMO): a record-linkage system for pharmacovigilance. Pharmaceut Med 1995;9:177-84.
15. Morris AD, Boyle DIR, MacAlpine R, Emslie-Smith A, Jung RT, Newton RW, et al. The diabetes audit and research in Tayside Scotland (DARTS) study: electronic record linkage to create a diabetes register. BMJ 1997;315:524-8.
16. Information and Statistics Division. Scottish health statistics 1996. Edinburgh: ISD Scotland Publications, 1996.
17. Morris AD, Boyle DIR, McMahon AD, Greene SA, MacDonald TM, Newton RW. Adherence to insulin treatment, glycaemic control and ketoacidosis in insulin dependent diabetes mellitus. Lancet 1997;350:1505-10.
18. Morris AD, Boyle DIR, McMahon AD, Pearce H, Evans JMM, Newton RW, et al. ACE inhibitor use is associated with hospitalization for severe hypoglycemia in patients with diabetes. Diabetes Care 1997;20:1363-7.
19. Morris AD, MacAlpine R, Steinke DT, Boyle DIR, MacDonald TM, Jung RT, et al. Diabetes associated lower extremity amputation in the community: a retrospective cohort study. Diabetes Care 1998;21:738-43.
20. Carstairs V. Deprivation and health in Scotland. Health Bull (Edinb) 1990;48:162-75.
21. British Medical Association, Royal Pharmaceutical Society of Great Britain. British national formulary. London: BMS, RPS, 1998. (No 35.)
22. Beardon PHG, McGilchrist MM, McKendrick AD, McDevitt DG, MacDonald TM. Primary non-compliance with prescribed medication in primary care. BMJ 1993;307:846-8.
23. Kurtz MS. Adhercnce to diabetes regimens: empirical status and clinical implications. Diabetes Educ 1990;16:50-6.
24. Anonymous. Economic consequences of diabetes in the US in 1997. American Diabetes Association. Diabetes Care 1998;21:296-309.